RecallDepth
Class II Ongoing

Paroxetine Hydrochloride Tablets USP, RX only, 10 mg a) 30-count bottle, NDC#: 60505-0097-1; b) 100-count bottle, NDC#: 60505-0097-2; c) 1000-count bottle, NDC#: 60505-0097-4, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.

This recall is currently active, issued December 6, 2023. It was issued by Apotex Corp..

Company
Apotex Corp.
Recall Initiated
November 1, 2023
Posted
December 6, 2023
Recall Number
D-0119-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
34,392
Firm Location
Weston, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Distribution

Nationwide

Lot / Code Info

Lot numbers: a)100 count bottle: RV2376, RV2377; b) 1000 count bottle: RV2379, RV2380; c) 30 count bottle: RV2375; Exp. 08/2024

More recalls by Apotex Corp.

View all recalls by this company →

Other recent Class II Drug recalls